Kalaris Therapeutics
(NASDAQ) KLRS
Kalaris Therapeutics Financials at a Glance
Market Cap
$143.76M
Revenue (TTM)
$0.00
Net Income (TTM)
$43.44M
EPS (TTM)
$-4.20
P/E Ratio
-1.49
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Price
$6.63
Volume
8,558
Open
$6.20
Price
$6.63
Volume
8,558
Open
$6.20
Previous Close
$6.63
Daily Range
$6.10 - $6.74
52-Week Range
$2.14 - $11.88
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Price
$6.63
Volume
8,558
Open
$6.20
Previous Close
$6.63
Daily Range
$6.10 - $6.74
52-Week Range
$2.14 - $11.88
KLRS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kalaris Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
20
CEO
Andrew Oxtoby, MBA
Website
www.kalaristx.comHeadquarters
Cambridge, MA 02142, US
KLRS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-45%
Return on Capital
-41%
Return on Assets
-36%
Earnings Yield
-67.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$143.76M
Shares Outstanding
22.93M
Volume
8.56K
Short Interest
0.00%
Avg. Volume
65.06K
Financials (TTM)
Gross Profit
$13.00K
Operating Income
$46.15M
EBITDA
$46.14M
Operating Cash Flow
$42.98M
Capital Expenditure
$200.00K
Free Cash Flow
$43.18M
Cash & ST Invst.
$117.98M
Total Debt
$1.45M
Kalaris Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$10.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$143.76M
N/A
Market Cap/Employee
$10.27M
N/A
Employees
14
N/A
Net Income
$10.00M
+45.3%
EBITDA
$10.79M
+40.9%
Quarterly Fundamentals
Net Cash
$116.53M
-1.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.13M
N/A
Short Term Debt
$316.00K
N/A
Return on Assets
-35.68%
N/A
Return on Invested Capital
-41.20%
N/A
Free Cash Flow
$9.33M
-115.7%
Operating Cash Flow
$9.32M
-115.3%